| Renal disease, Chronic Alcoholism, Epilepsy, Depression, Psychiatric disease, Hypothyroidism, Diabetes. Not recommended in patients with Acute Porphyria, Closely Monitor when co-administered with Cycloserine, Monitor serum Transaminases before and every 2 to 4 weeks during Ethionamide therapy. |